BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PSA
24693 results:

  • 1. Salvage Radiotherapy PSMA PET/CT-guided in Men With psa Recurrence.
    Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
    Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
    Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
    Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in prostate cancer Cells.
    Champagne A; Chebra I; Jain P; Ringuette Goulet C; Lauzier A; Guyon A; Neveu B; Pouliot F
    Biosensors (Basel); 2024 Apr; 14(4):. PubMed ID: 38667168
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.
    Tang Y; Gao Y; Zhang R; Li T; Yang Y; Huang L; Wei Y
    Sci Rep; 2024 Apr; 14(1):9494. PubMed ID: 38664545
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic Correlates of prostate-Specific Membrane Antigen Expression and Response to
    Raychaudhuri R; Mo G; Tuchayi AM; Graham L; Gulati R; Pritchard CC; Haffner MC; Yezefski T; Hawley JE; Cheng HH; Yu EY; Grivas P; Montgomery RB; Nelson PS; Chen DL; Hope T; Iravani A; Schweizer MT
    JCO Precis Oncol; 2024 Apr; 8():e2300634. PubMed ID: 38662984
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [prostate cancer - a disease in transformation].
    Bratt O
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38661575
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Molecular subtypes provide possibilities for precision medicine in a advanced prostate cancer].
    Wikström P; Bergh A; Josefsson A; Thysell E; Welén K
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38656744
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Exploration and validation of optimal cut-off values for tpsa and fpsa/tpsa screening of prostate cancer at different ages].
    Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
    [No Abstract]    [Full Text] [Related]  

  • 9. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized prostate cancer.
    Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
    Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Study on the length and quality of prostate biopsy tissue strips].
    Geng YS; Gao YQ; Cao FH; Wu S; Ding XF
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):1000-1005. PubMed ID: 38639952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Influence factors of erectile dysfunction in patients with localized prostate cancer after radical surgery].
    Wang SH; Shi XQ; Ma MF; Jin XX; Zhao XD; Zhou YL; Gu YF; Hu J; Dong N; Dong J; Xu S
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):992-999. PubMed ID: 38639951
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Study on the efficacy and complications of patients undergoing radical surgery and radical radiotherapy for localized prostate cancer].
    Shi XQ; Wang SH; Liu Z; Lu LW; Xu S; Fu D; Cheng W
    Zhonghua Nan Ke Xue; 2023 Oct; 29(10):910-915. PubMed ID: 38639661
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
    Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
    Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model.
    Bastian JLD; Zeuschner P; Stöckle M; Junker K; Linxweiler J
    Sci Rep; 2024 Apr; 14(1):8835. PubMed ID: 38632341
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A pictorial view on false positive findings of
    Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
    Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (psa) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest.
    Liu HE; Vuppalapaty M; Hoerner CR; Bergstrom CP; Chiu M; Lemaire C; Che J; Kaur A; Dimmick A; Liu S; Metzner TJ; Araya M; Crouse S; Sprenger-Haussels M; Schlumpberger M; Leppert JT; Hauch S; Sollier E; Fan AC
    BMC Cancer; 2024 Apr; 24(1):482. PubMed ID: 38627648
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
    Gronnier M; Hedhli K; Sauzay C; Salle V; Duhaut P; Schmidt J; Dernoncourt A
    BMC Cancer; 2024 Apr; 24(1):468. PubMed ID: 38622530
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinical study of artificial intelligence-guided image fusion assisted transperineal prostate biopsy].
    Hu J; Zhao XD; Zhou YL; Dong N; Ma MF; Chen YH; Sheng ZC; Dong J; He CQ; Xu S
    Zhonghua Nan Ke Xue; 2023 Aug; 29(8):729-735. PubMed ID: 38619521
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Difference between prostate cancer patients' Gleason scores from preoperative biopsy and those from postoperative pathology].
    Zhao XD; Liu YH; Hu J; Wang ZH; Jin XX; Ma MF; Zhou YL; Chen YH; Cao J; Dong J; Xu S
    Zhonghua Nan Ke Xue; 2023 May; 29(5):393-401. PubMed ID: 38602754
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Provider Perceptions of an Electronic Health Record prostate cancer Screening Tool.
    Carlsson SV; Preston M; Vickers A; Malhotra D; Ehdaie B; Healey M; Kibel AS
    Appl Clin Inform; 2024 Mar; 15(2):282-294. PubMed ID: 38599619
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1235.